A survey by Roche Diagnostics of 2,836 women aged 25 to 50 from eight Asia-Pacific countries discovered that 44 per cent of respondents delayed or avoided medical treatment because of familial ...

To get from Nice to Port-Fréjus, where Stephen Roche suggests we first meet, the motorway sweeps up and around the Cote d’Azur, bypassing familiar names such as Sainte-Maxime, St-Raphaël ...

Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...

Gone are the days you had to use the same plain-red heart emoji in every text, email, and Instagram caption. In 2023, your emoji keyboard features hearts in pretty much every colour, shape ...

Zepzelca, used in combination with Roche’s Tecentriq, outperformed Tecentriq alone when used as a first-line maintenance treatment in ES-SCLC following induction therapy with Tecentriq and chemo ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The news came as Roche recorded a 10% increase in first-quarter revenues to CHF 16.4 billion ($17.2 billion), on strong US demand for rapid COVID-19 antigen tests, as well as the performances of ...

Australia has committed up to $600 million over a decade to bolster PNG's pitch to secure a team in the competition, with the NRL set to make a final decision in coming weeks. But the ABC revealed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Brian Roche co-anchors News 8 at 5 p.m. each weekday. He is also the 8 On Your Side Consumer/Investigative reporter for News 8. Brian is an Emmy Award winning anchor and reporter. He has been ...

1 Day ROG -1.02% DJIA 0.59% S&P 500 0.38% Health Care/Life Sciences 2.54% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...